hotspot -WSS

hotspot

author：knowledge 2025-10-01 00:59:41 - browse：9994

Why are addiction treatments so hard to get? Can small companies compete in obesity? And since when is “Series E” a thing in biotech?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. For the entirety of the opioid overdose epidemic, the U.S. has had readily available tools that are proven to save lives. STAT’s Lev Facher joins us to explain his reporting on why virtually every sector of American society is standing in the way of their use. We also discuss the latest news in the life sciences, including the haves and have-nots of venture capital, and the race to develop effective oral treatments for obesity.

For more on what we cover, here’s the story on addiction medicine; here’s the latest on biotech financing; here’s more on Novo Nordisk’s oral obesity treatment; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Hollywood unions extend contract negotiations for actors
Next article： A preacher's new calling: Diversifying neuroscience research

WSS

American taxpayers paid $1.8 trillion in health care costs in 2022

Kenai launches with $82 million for Parkinson’s stem cell therapy

Boston Scientific acquires urology company Axonics for $3.7 billion

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

RSV vaccines may be linked to small increased risk of developing GBS

American taxpayers paid $1.8 trillion in health care costs in 2022

focus

hotspot

focus

At least 13 dead in Texas as scorching temps continue

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

ChatGPT in medicine: STAT answers readers' burning questions

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Virginia high school admissions case could be legal follow

STAT Virtual Event: JPM Recap, Live!

After affirmative action ruling, medical educators look to 'holistic review'

STAT Virtual Event: JPM Recap, Live!

Activists slam private health insurers over coverage restrictions

Change Healthcare cyberattack outage could last weeks

focus

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

Biotech companies concerned about China biosecurity crackdown

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

FDA does about

Why getting cancer drugs just got harder for rural patients

In shift, Texas to cover initial consult for Afghan baby's gene therapy

explore

hotspot

hotspot

focus